News roundup
Biopharma News Round Up 7–11th September
This week's biopharma news was led by oncology readouts, regulatory momentum in rare disease, and a handful of notable pipeline setbacks.
Read article →This week's biopharma news was led by oncology readouts, regulatory momentum in rare disease, and a handful of notable pipeline setbacks.
Read article →Approvals, Phase 3 Inflection Points, and Cell-Therapy Safety Signals
Read article →